Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
Phenergan	O
/	O
Ambien	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Chest	O
pain,	O
shortness	O
of	O
breath	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
yo	O
M	O
with	O
recent	O
TURP	O
now	O
w/L	O
flank	O
pain,	O
progressive	O
SOB	O
for	O
several	O
weeks,	O
worse	O
over	O
last	O
several	O
days.	O
patient	O
states	O
he	O
usually	O
can	O
walk	O
around	O
the	O
pond	O
without	O
difficulty,	O
but	O
several	O
days	O
ago	O
was	O
only	O
able	O
to	O
get	O
___round	O
and	O
had	O
to	O
turn	O
around	O
because	O
of	O
shortness	O
of	O
breath.	O
He	O
denies	O
PND	O
or	O
orthopnea.	O
His	O
chest	O
pain	O
is	O
worse	O
with	O
inspiration,	O
radiating	O
to	O
the	O
back,	O
located	O
primarily	O
on	O
the	O
lower	O
left	O
thorax.	O
Not	O
associated	O
with	O
exercise.	O
He	O
states	O
he	O
has	O
been	O
healing	O
well	O
from	O
his	O
prostate	O
procdure.	O
Denies	O
chest	O
pain,	O
no	O
cough,	O
no	O
dysuria.	O
In	O
ED:	O
VS:	O
71	O
139/75	O
18	O
98%	O
RA	O
AF.	O
Had	O
CTA	O
in	O
ED	O
showing	O
PE.	O
EKG	O
NSR.	O
Admitted	O
on	O
heparin	O
gtt.	O
On	O
transfer	O
to	O
the	O
floor	O
patient	O
feels	O
well.	O
Denies	O
CP,	O
no	O
SOB	O
currently.	O
ROS:	O
As	O
above	O
and	O
denies	O
fever,	O
chills,	O
night	O
sweats,	O
headache,	O
vision	O
changes,	O
rhinorrhea,	O
congestion,	O
sore	O
throat,	O
cough,	O
abdominal	O
pain,	O
nausea,	O
vomiting,	O
diarrhea,	O
constipation,	B-Constipation
BRBPR,	B-Lower_gastrointestinal_haemorrhage
melena,	B-Upper_gastrointestinal_haemorrhage
hematochezia,	B-Lower_gastrointestinal_haemorrhage
dysuria,	O
hematuria.	O
Past	O
Medical	O
History:	O
CAD	O
s/p	O
CABG	O
X	O
___	O
(RCA)	O
HTN	O
Hyperlipidemia	O
Actinic	O
Keratosis	O
BPH	O
s/p	O
TURP	O
___	O
GERD	O
H/o	O
Cholelithiasis	O
s/p	O
ERCP	O
Chronic	O
Renal	O
failure,	O
baseline	O
Cr	O
1.4	O
Social	O
History:	O
___	O
Family	O
History:	O
NC	O
Physical	O
Exam:	O
On	O
Presentation:	O
VSS:	O
AF	O
BP	O
130/62	O
HR	O
76	O
RR	O
15	O
96%	O
on	O
2Lnc	O
GENERAL:	O
NAD,	O
well	O
apeparing	O
elderly	O
male	O
HEENT:	O
EOMI,	O
PERRL,	O
mmm,	O
no	O
OP	O
lesions	O
CARDIAC:	O
regular	O
rate,	O
no	O
mrg	O
LUNG:	O
bibasilar	O
crackles	O
L>R	O
ABDOMEN:	O
+bs,	O
soft,	O
NTND,	O
no	O
HSM	O
EXT:	O
No	O
___,	O
2+	O
DP	O
pulses,	O
warm,	O
well	O
perfused	O
NEURO:	O
a/o	B-Delirium
x3,	O
___	O
strength	O
___	O
B,	O
sensation	O
intact,	O
CN	O
___	O
intact	O
DERM:	O
no	O
skin	O
lesions	O
Pertinent	O
Results:	O
CHEST	O
CT:	O
1.	O
Segmental	O
pulmonary	O
embolus.	O
2.	O
Numerous	O
calcified	O
and	O
noncalcified	O
granulomas	O
are	O
stable.	O
While	O
stable	O
as	O
well,	O
the	O
ground	O
glass	O
nodules	O
likely	O
warrant	O
a	O
follow	O
up	O
CT	O
to	O
help	O
exclude	O
indolent	O
neoplasms	O
(e.g.	O
bronchoalveolar	O
cell	O
carcinoma).	O
3.	O
Pneumobilia.	O
Given	O
prior	O
sphincterotomy,	O
this	O
is	O
an	O
expected	O
finding.	O
4.	O
Vascular,	O
including	O
coronary	O
artery,	O
calcifications.	O
DISCHARGE	O
LABS:	O
-	O
WBC-6.9	O
RBC-3.70*	O
Hgb-11.6*	O
Hct-33.5*	O
MCV-91	O
MCH-31.4	O
MCHC-34.7	O
RDW-13.5	O
Plt	O
___	O
-	O
___	O
PTT-95.4*	O
___	O
-	O
Glucose-117*	O
UreaN-27*	O
Creat-1.4*	O
Na-137	O
K-3.5	O
Cl-105	O
HCO3-22	O
AnGap-14	O
-	O
D-Dimer-4196*	O
Brief	O
Hospital	O
Course:	O
___	O
yo	O
M	O
with	O
PMH	O
of	O
CAD,	O
HTN,	O
HLP,	O
BPH,	O
chronic	O
renal	O
failure,	O
GERD	O
admitted	O
with	O
SOB	O
found	O
to	O
have	O
PE.	O
Treated	O
initially	O
with	O
heparin	O
drip	O
with	O
bridging	O
to	O
coumadin.	O
Heparin	O
was	O
d/c'ed	O
and	O
patient	O
was	O
initiated	O
on	O
___.	O
He	O
was	O
discharged	O
home	O
in	O
stable	O
condition	O
with	O
visting	O
nurse	O
services	O
to	O
administer	O
___	O
and	O
daily	O
INR	O
checks	O
until	O
therapeutic	O
(INR	O
___	O
on	O
coumadin	O
for	O
2	O
days.	O
He	O
will	O
be	O
followed	O
by	O
___	O
___	O
clinic.	O
#	O
Pulmonary	O
Embolus:	O
Found	O
on	O
CT,	O
was	O
likely	O
causing	O
progressive	O
SOB.	O
Likely	O
post-operative	O
given	O
recent	O
TURP.	O
Could	O
consider	O
out	O
pt	O
malignancy	O
w/u.	O
Treated	O
initially	O
with	O
heparin	O
drip	O
with	O
bridging	O
to	O
coumadin.	O
Heparin	O
was	O
d/c'ed	O
and	O
patient	O
was	O
initiated	O
on	O
___.	O
He	O
was	O
discharged	O
home	O
in	O
stable	O
condition	O
with	O
visting	O
nurse	O
services	O
to	O
administer	O
___	O
and	O
bi-weekly	O
INR	O
checks	O
until	O
therapeutic	O
(INR	O
___	O
on	O
coumadin.	O
He	O
will	O
be	O
followed	O
by	O
___	O
clinic.	O
#	O
Chest	O
Pain:	O
Resolved	O
prior	O
to	O
discharge.	O
Was	O
pleuritic	O
in	O
nature,	O
L	O
side,	O
likely	O
___	O
PE	O
which	O
is	O
in	O
LLL	O
segment.	O
#	O
Hematuria:	O
Had	O
tea	O
colored	O
urine,	O
UA	O
with	O
moderate	O
blood	O
but	O
only	O
4	O
RBC.	O
Hct	O
has	O
been	O
stable,	O
no	O
urinary	O
retention.	O
Likely	O
___	O
TURP.	O
CK	O
wnl.	O
Hct	O
stable.	O
#	O
Leukocytosis:	O
11.6	O
on	O
admission	O
but	O
resolved.	O
Likely	O
occurred	O
in	O
setting	O
of	O
PE,	O
normal	O
diff.	O
Was	O
afberile	O
through	O
hospitalization.	O
#	O
Chronic	O
Renal	O
Failure:	O
At	O
baseline	O
of	O
1.4.	O
Continued	O
ACEi.	O
Medications	O
renally	O
dose.	O
#	O
CAD:	O
Had	O
pleuritic	O
chest	O
pain	O
as	O
above,	O
likely	O
___	O
PE.	O
He	O
was	O
s/p	O
CABG	O
X	O
___	O
(RCA).	O
Continued	O
home	O
BB,	O
ASA,	O
statin.	O
EKG	O
was	O
wnl.	O
Trop	O
negative.	O
Was	O
not	O
fully	O
ruled	O
out	O
for	O
MI.	O
#	O
HTN:	O
BP's	O
well	O
controlled.	O
Continued	O
home	O
BB,	O
ACEi,	O
HCTZ.	O
#	O
Hyperlipidemia:	O
Continued	O
home	O
statin,	O
last	O
panel:	O
total	O
177,	O
LDL	O
97,	O
HDL	O
84	O
#	O
DM	O
II:	O
Diet	O
controlled.	O
#	O
BPH	O
s/p	O
TURP	O
___:	O
Healing	O
well,	O
in	O
no	O
pain.	O
Urology	O
saw	O
on	O
admission	O
in	O
ED.	O
Hematuria	O
w/u	O
tx	O
as	O
above.	O
#	O
GERD:	O
Continued	O
home	O
PPI.	O
#	O
PPX:	O
received	O
heparin	O
#	O
Code:	O
FULL	O
Medications	O
on	O
Admission:	O
Atorvastatin	O
80	O
mg	O
Tablet	O
qd	O
Enalapril	O
10	O
mg	O
bid	O
Hydrochlorothiazide	O
25	O
mg	O
qd	O
Metoprolol	O
Tartrate	O
100	O
bid	O
Omeprazole	O
20	O
mg	O
qd	O
Aspirin	O
325	O
mg	O
qd	O
Calcium	O
Carbonate	O
[Tums]	O
1	O
tab	O
tid	O
Cholecalciferol	O
(Vitamin	O
D3)	O
1,000	O
unit	O
qd	O
Docusate	O
100	O
mg	O
bid	O
prn	O
Multivitamin	O
1	O
tab	O
qd	O
Discharge	O
Medications:	O
1.	O
Atorvastatin	O
80	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
2.	O
Enalapril	O
Maleate	O
10	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
3.	O
Hydrochlorothiazide	O
12.5	O
mg	O
Capsule	O
Sig:	O
Two	O
(2)	O
Capsule	O
PO	O
DAILY	O
(Daily).	O
4.	O
Metoprolol	O
Tartrate	O
50	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
5.	O
Omeprazole	O
20	O
mg	O
Capsule,	O
Delayed	O
Release(E.C.)	O
Sig:	O
One	O
(1)	O
Capsule,	O
Delayed	O
Release(E.C.)	O
PO	O
DAILY	O
(Daily).	O
6.	O
Aspirin	O
325	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
7.	O
Calcium	O
Carbonate	O
500	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
TID	O
(3	O
times	O
a	O
day).	O
8.	O
Cholecalciferol	O
(Vitamin	O
D3)	O
400	O
unit	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
9.	O
Multivitamin	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
10.	O
Warfarin	O
7.5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
Once	O
Daily	O
at	O
4	O
___.	O
Disp:*30	O
Tablet(s)*	O
Refills:*2*	O
11.	O
___	O
7.5	O
mg/0.6	O
mL	O
Syringe	O
Sig:	O
Seven	O
(7)	O
syringes	O
Subcutaneous	O
DAILY	O
(Daily)	O
for	O
7	O
days:	O
take	O
until	O
INR	O
___	O
for	O
2	O
days.	O
Disp:*7	O
syringes*	O
Refills:*0*	O
Discharge	O
Disposition:	O
Home	B-Has_carers
With	B-Has_carers
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Primary:	O
Pulmonary	O
Embolus	O
Secondary:	O
CAD	O
s/p	O
CABG	O
X	O
___	O
(RCA)	O
HTN	O
Hyperlipidemia	O
Actinic	O
Keratosis	O
BPH	O
s/p	O
TURP	O
___	O
GERD	O
H/o	O
Cholelithiasis	O
s/p	O
ERCP	O
Chronic	O
Renal	O
failure,	O
baseline	O
Cr	O
1.4	O
Discharge	O
Condition:	O
Stable	O
vitals,	O
ambulating	O
without	O
difficulty,	O
satin	O
well	O
on	O
room	O
air.	O
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
with	O
chest	O
pain	O
and	O
shortness	O
of	O
breath	O
and	O
were	O
found	O
to	O
have	O
a	O
clot	O
in	O
your	O
lung.	O
You	O
were	O
initially	O
treated	O
with	O
IV	O
medication	O
and	O
oral	O
medication.	O
You	O
are	O
being	O
discharged	O
on	O
the	O
oral	O
medication,	O
called	O
coumadin	O
which	O
you	O
will	O
need	O
to	O
take	O
for	O
at	O
least	O
6	O
months.	O
Additionally,	O
because	O
it	O
can	O
take	O
several	O
days	O
for	O
the	O
oral	O
medication	O
to	O
have	O
effect,	O
you	O
will	O
also	O
received	O
a	O
shot	O
from	O
visiting	O
nurses	O
for	O
several	O
days	O
to	O
ensure	O
that	O
your	O
blood	O
is	O
adequately	O
thinned	O
while	O
the	O
oral	O
medication	O
takes	O
effect.	O
This	O
medication	O
is	O
called	O
___.	O
The	O
oral	O
medication	O
(Coumadin)	O
needs	O
to	O
be	O
closely	O
monitored	O
to	O
ensure	O
that	O
the	O
levels	O
in	O
your	O
blood	O
are	O
not	O
too	O
low	O
and	O
not	O
too	O
high.	O
You	O
will	O
need	O
to	O
have	O
your	O
blood	O
drawn	O
several	O
times	O
a	O
week	O
in	O
order	O
to	O
ensure	O
this.	O
The	O
results	O
of	O
the	O
blood	O
tests	O
will	O
be	O
faxed	O
to	O
___	O
at	O
___	O
and	O
if	O
you	O
need	O
to	O
change	O
the	O
dose	O
of	O
the	O
medication,	O
___	O
will	O
call	O
you	O
to	O
let	O
you	O
know.	O
When	O
you	O
had	O
a	O
CT	O
scan	O
of	O
your	O
lungs	O
there	O
were	O
some	O
nodules	O
that	O
were	O
seen.	O
It	O
is	O
unclear	O
what	O
the	O
significance	O
of	O
these	O
lesions,	O
but	O
you	O
should	O
have	O
a	O
follow	O
up	O
CT	O
of	O
your	O
lungs	O
in	O
3	O
months	O
to	O
ensure	O
that	O
the	O
nodules	O
are	O
not	O
growing.	O
No	O
other	O
medication	O
changes	O
were	O
made.	O
You	O
should	O
continue	O
all	O
your	O
home	O
medications	O
as	O
previously	O
directed.	O
If	O
you	O
have	O
bleeding,	O
dark	B-Upper_gastrointestinal_haemorrhage
stool,	B-Upper_gastrointestinal_haemorrhage
chest	O
pain,	O
shortness	O
of	O
breath,	O
chest	O
pain,	O
abdominal	O
pain,	O
high	O
fever,	O
dizziness	O
or	O
lightheadedness	O
or	O
any	O
other	O
concerning	O
symptom,	O
please	O
seek	O
medical	O
care	O
immediately.	O
It	O
was	O
a	O
pleasure	O
meeting	O
you	O
and	O
participating	O
in	O
your	O
care.	O
Followup	O
Instructions:	O
___	O

